This article is freely available to all

Article Abstract

Current treatment options for patients with bipolar spectrum disorders are expanding. New evidence in the treatment of various phases of illness of bipolar disorder is emerging. Atypical antipsychotic medications, used as monotherapy or as adjunctive therapy with mood stabilizers, have shown efficacy as well as well-tolerated side effect profiles, thus becoming valuable new resources in the treatment of bipolar disorder.